Qsymia as an Adjunct to Surgical Therapy in the Superobese
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 22 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 22 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
- 18 May 2016 Status changed from recruiting to active, no longer recruiting.